Speaker illustration

Doctor Ezequiel Alvarez Castro

Universidad de Santiago de Compostela and CIBERCV, Santiago de Compostela (Spain)

Degree in Pharmacy by the University of Santiago de Compostela (USC, Spain) and PhD Thesis (2002) in Cardiovascular Pharmacology. Postdoctoral stage (2004-2007) in Centro de Investigações en Ciencias da Saúde (Beira Interior University, Covilhã, Portugal). Researcher (Isidro Parga Pondal Program) and professor at Medicine Department of the USC (2007–2011). From 2011 he leads a research line based on the study of the pathophysiology of human vascular endothelium at the Health Research Institute of Santiago de Compostela (IDIS, Spain). - Expertise: Cardiovascular Pharmacology; In vivo, in vitro and ex vivo experimentation with animals, cells and vascular tissues; Molecular biology; Electrophysiology (patch-clamp); Cellular signalling pathways. - Research interest: Cardiovascular pharmacology; Endothelial dysfunction; AGE (advanced glycation end-products); Cellular signalling; Atherosclerosis; Endothelial progenitor cells; New therapeutic targets; Drugs from natural origin; Drug discovery

New fluidic model for in vitro testing of vascular effects of drugs: 4D endothelial sensing (4D-ENDOSENS)

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Drugs, Drug Targets

Session: Poster Session 1

Thumbnail

ESC 365 is supported by

logo Novo Nordisk